
Zimmer Biomet Q3 2026 Results: Net Income $192 Million on Revenue of $2.06 Billion
Zimmer Biomet (NYSE: ZBH) reported GAAP revenue of $2.06 billion and GAAP net income of $191.6 million for the third quarter of 2026, the quarter ended 30 Sep 2026, and it said on 4 Nov 2026. GAAP diluted EPS was $1.00, and adjusted diluted EPS, a company-defined measure, was $1.90.
- US stocks
- Earnings